The objective of this review is to highlight the continued exclusion of discussion in the literature regarding alternative causes and proper causality assessment of cases of hepatotoxicity when use of dietary supplements is reported. Though independent experts are working diligently to advance the discussion related to alternative causes of hepatotoxicity resulting in idiosyncratic drug-induced liver injury/herb-induced liver injury (DILI/HILI), the literature continues to recite the same cases, such as those presented here, to reiterate potentially biased positions and ignore current, standardized and valid evaluations utilizing the Roussel Uclaf Causality Assessment Method (RUCAM). Several historical cases purporting hepatotoxicity induced by use of dietary supplements are presented in this review to demonstrate how such cases may be improperly assessed due to bias, inconsistent use of causality assessment methods, as well as use of causality assessment methods deemed obsolete. This in essence, delays any true progress in establishing sound criteria to determine and address the actual cause(s) of DILI/HILI.
Teschke, R., Wolff, A., Frenzel, C., Schulze, J. and Eickhoff, A. (2012) Herbal Hepatotoxicity: A Tabular Compilation of Reported Cases. Liver International, 32, 1543-1556. http://dx.doi.org/10.1111/j.1478-3231.2012.02864.x
Teschke, R., Frenzel, C., Schulze, J., Schwarzenboeck, A. and Eickhoff, A. (2013) Herbalife Hepatotoxicity: Evaluation of Cases with Positive Reexposure Tests. World Journal of Hepatology, 5, 353-363. http://dx.doi.org/10.4254/wjh.v5.i7.353
Teschke, R., Schulze, J., Schwarzenboeck, A., Eickhoff, A. and Frenzel, C. (2013) Herbal Hepatotoxicity: Suspected Cases Assessed for Alternative Causes. European Journal of Gastroenterology & Hepatology, 25, 1093-1098. http://dx.doi.org/10.1097/MEG.0b013e3283603e89
Zambrone, F.A., Corrêa, C.L. and Amaral, L.M. (2015) A Critical Analysis of the Hepatotoxicity Cases Described in the Literature Related to Herbalife? Products. Brazilian Journal of Pharmaceutical Sciences, 51, 785-796. http://dx.doi.org/10.1590/S1984-82502015000400004
Anderson, J.W. and Konz, E.C. (2001) Obesity and Disease Management: Effects of Weight Loss on Comorbid Conditions. Obesity Research, 9, 326S-334S. http://dx.doi.org/10.1038/oby.2001.138
Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M. and Sanyal, A.J. (2012) The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55, 2005-2023. http://dx.doi.org/10.1002/hep.25762
Promrat, K., Kleiner, D.E., Niemeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., Fava, J.L. and Wing, R.R. (2001) Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis. Hepatology, 51, 121- 129. http://dx.doi.org/10.1002/hep.23276
Schaffer, J.E. (2003) Lipotoxicity: When Tissues Overeat. Current Opinion in Lipidology, 14, 281-287. http://dx.doi.org/10.1097/00041433-200306000-00008
Brookheart, R.T., Michel, C.I. and Schaffer, J.E. (2009) As a Matter of Fat. Cell Metabolism, 10, 9-12. http://dx.doi.org/10.1016/j.cmet.2009.03.011
Neuschwander-Tetri, B.A. (2010) Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites. Hepatology, 52, 774-788. http://dx.doi.org/10.1002/hep.23719
Caprai, S., Vajro, P., Ventura, A., Sciveres, M. and Maggiore, G. (2008) SIGENP Study Group for Autoimmune Liver Disorders in Celiac Disease. Autoimmune Liver Disease Associated with Celiac Disease in Childhood: A Multicenter Study. Clinical Gastroenterology and Hepatology, 6, 803-806. http://dx.doi.org/10.1016/j.cgh.2007.12.002
Villalta, D., Girolami, D., Bidoli, E., Bizzaro, N., Tampoia, M., Liguori, M., Pradella, M., Tonutti, E. and Tozzoli, R. (2005) High Prevalence of Celiac Disease in Autoimmune Hepatitis Detected by Anti-Tissue Tranglutaminase Autoantibodies. Journal of Clinical Laboratory Analysis, 19, 6-10. http://dx.doi.org/10.1002/jcla.20047
Volta, U. (2009) Pathogenesis and Clinical Significance of Liver Injury in Celiac Disease. Clinical Reviews in Allergy & Immunology, 36, 62-70. http://dx.doi.org/10.1007/s12016-008-8086-x
Guturu, P. and Duchini, A. (2012) Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity, Insulin Resistance and Mechanisms of Hepatotoxicity. International Journal of Hepatology, 2012, 8 p.
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M. and Marchesini, G. (2005) Endothelial Dysfunction and Cardiovascular Risk Profile in Nonalcoholic Fatty Liver Disease. Hepatology, 42, 473-480. http://dx.doi.org/10.1002/hep.20781
Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G. and Leo, E. (2007) A Prospective Study of Acute Drug-Induced Liver Injury in Patients Suffering from Non-Alcoholic Fatty Liver Disease. Hepatology Research, 37, 410-415. http://dx.doi.org/10.1111/j.1872-034X.2007.00072.x
Dalton, H.R., Fellows, H.J., Stableforth, W., Joseph, M., Thurairajah, P.H., Warshow, U., Hazeldine, S., Remnarace, R., Ijaz, S., Hussaini, S.H. and Bendall, R.P. (2007) The Role of Hepatitis E Virus Testing in Drug-Induced Liver Injury. Alimentary Pharmacology & Therapeutics, 26, 1429-1435. http://dx.doi.org/10.1111/j.1365-2036.2007.03504.x
Davern, T.J., Chalasani, N., Fontana, R.J., Hayashi, P.H., Protiva, P., Kleiner, D.E., Engle, R.E., Nguyen, H., Emerson, S.U., Purcell, R.H., Tillmann, H.L., et al. (2011) Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury. Gastroenterology, 141, 1665-1672.e9. http://dx.doi.org/10.1053/j.gastro.2011.07.051
Elinav, E., Pinsker, G., Safadi, R., Pappo, O., Bromberg, M., Anis, E., Keinan-Boker, L., Broide, E., Ackerman, Z., Kaluski, D.N. and Lev, B. (2007) Association between Consumption of Herbalife? Nutritional Supplements and Acute Hepatotoxicity. Journal of Hepatology, 47, 514-520. http://dx.doi.org/10.1016/j.jhep.2007.06.016
Johannsson, M., Ormarsdottir, S. and Olafsson, S. (2010) Hepatotoxicity Associated with the Use of Herbalife. Laeknabladid, 96, 167-172.
Manso, G., López-Rivas, L., Salgueiro, M.E., Duque, J.M., Jimeno, F.J., Andrade, R.J. and Lucena, M.I. (2011) Continuous Reporting of New Cases in Spain Supports the Relationship between Herbalife? Products and Liver Injury. Pharmacoepidemiology and Drug Safety, 20, 1080-1087. http://dx.doi.org/10.1002/pds.2180
Schoepfer, A.M., Engel, A., Fattinger, K., Marbet, U.A., Criblez, D., Reichen, J., Zimmermann, A. and Oneta, C.M. (2007) Herbal Does Not Mean Innocuous: Ten Cases of Severe Hepatotoxicity Associated with Dietary Supplements from Herbalife? Products. Journal of Hepatology, 47, 521-526. http://dx.doi.org/10.1016/j.jhep.2007.06.014